11/24
08:05 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.
11/6
06:56 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/4
08:05 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was given a new $7.00 price target on by analysts at Guggenheim.
Low
Report
Pyxis Oncology (NASDAQ:PYXS) was given a new $7.00 price target on by analysts at Guggenheim.
11/3
04:05 pm
pyxs
Pyxis Oncology to Participate in Upcoming Investor Conferences
Low
Report
Pyxis Oncology to Participate in Upcoming Investor Conferences
11/3
10:59 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.
11/3
07:00 am
pyxs
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
Medium
Report
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
10/15
07:11 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/13
04:21 pm
pyxs
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings [Yahoo! Finance]
Medium
Report
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings [Yahoo! Finance]
10/13
04:05 pm
pyxs
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
Medium
Report
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
10/9
07:50 am
pyxs
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets [Yahoo! Finance]
High
Report
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets [Yahoo! Finance]
10/9
07:30 am
pyxs
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
High
Report
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
10/4
12:07 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
10/1
09:23 am
pyxs
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer [Yahoo! Finance]
Low
Report
Maxion Therapeutics Appoints Joel Edwards as Chief Business Officer [Yahoo! Finance]
9/30
04:24 pm
pyxs
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/6
06:47 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
Pyxis Oncology (NASDAQ:PYXS) was upgraded by analysts at Guggenheim to a "strong-buy" rating.